azacitidine BE study [Design Issues]

posted by arunkumar – 2009-06-03 15:41 (6228 d 05:09 ago) – Posting: # 3812
Views: 5,347

can somebody contribute on the design of azacitidine BE study in patients with MDS (myelodysplatic syndrome)?
generally is it done as two period cross over study or as the evaluation of steady state PK?
also any tips for the BA method of azacitidine such as equipment, range, etc..?

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
139 visitors (0 registered, 139 guests [including 26 identified bots]).
Forum time: 20:50 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5